BioBuzz’s 2022 Top 5 “5 Questions With…”

Published on : Published by : BioBuzz Media

We at BioBuzz have always strived to center ourselves around the individuals who have worked to push the biohealth sphere to new heights. Our “5 Questions With…” series embodies this effort as we have highlighted professionals at all levels, from early career to the C-suite, from scientists to business developers to managers and directors. Regardless of position or title, the many individuals highlighted in 2022 are all changemakers in their own right and we greatly appreciate their work and contribution to this series. 

Announcing Your 3rd Annual BioBuzz Awards Finalists

Published on : Published by : BioBuzz Media

We’re excited to announce this year’s finalists for the third annual 2022 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.

How U.S. Pharmacopeia (USP) Plays a Crucial Role in Bringing New Medicines to Market

Published on : Published by : Steven Surdez

Headquartered in Rockville, Maryland, USP employs approximately 1,300 staff members and has locations across the globe. USP has three primary areas of focus: medicines, food, and dietary supplements. For two centuries, USP has been on a mission to create a world where all have access to high-quality, safe, and beneficial medicines. The non-profit organization is in the business of protecting patients through rigorous science, stringent safety and quality standards, and strong supply chain management that gets safe and efficacious medicines to those in need. 

How Do We Bolster the BioHealth Capital Region Workforce?

Published on : Published by : Erika Riley

As more life science companies flock to the region a new challenge arises – how do we create a strong pipeline of local talent to support their needs? This pipeline not only includes the high concentration of experienced talent the BHCR is known for but entry-level employees and people without four-year degrees who can be trained on-the-job.

BioHealth Capital Region Forum 2022 Preview

Published on : Published by : Steven Surdez

There is no better way to get a glimpse into the future of the region’s life sciences ecosystem than the 8th annual BioHealth Capital Region (BHCR) Forum, which is fast approaching. The 2022 BHCR Forum is a can’t miss in-person/live streamed event hosted at United States Pharmacopeia (USP) in Rockville, Maryland on September 20th. Also, on September 21st at USP will be the  5th Annual BioHealth Capital Region Investment Conference and the 7th Annual Crab Trap Competition. 

U.S. Pharmacopeia Medicine Supply Map Analysis Shows Increased Shortage Risk for Antibiotics  

Published on : Published by : BioBuzz Media

Antibiotics are 42% more likely to be in shortage compared to all other drugs, according to the latest analysis from the U.S. Pharmacopeia’s (USP) Medicine Supply Vulnerability Insights Series. The findings are sourced from USP’s global Medicine Supply Map, derived from 40 external datasets and proprietary information about the use of USP quality standards, spanning 92% of generic medicines approved in the U.S. 

5 Questions With Vimala Raghavendran, Senior Director and Head of USP Pharmaceutical Supply Chain Center

Published on : Published by : BioBuzz Media

Vimala Raghavendran leads the U.S. Pharmacopeia (USP) Pharmaceutical Supply Chain Center, which houses the USP Medicine Supply Map, an information system that identifies, characterizes, and quantifies risk in the upstream pharmaceutical supply chain so that stakeholders can prioritize supply chain investments and prevent drug shortages.

USP Director Dr. Farah Towfic Honored with Montgomery County 2022 Women Making History Award

Published on : Published by : BioBuzz Media

U.S. Pharmacopeia is pleased to announce that Dr. Farah Towfic, PharmD, MBA, RPh, Director of CEO Operations has been recognized among 31 outstanding women recipients of the 2022 Women Making History Award for her extraordinary work as part of USP’s response to the COVID-19 crisis.

COVID Vaccines Demonstrated the Potential of mRNA Technology but Common Approaches for Managing Quality are Needed

USP Logo
Published on : Published by : BioBuzz Media

U.S. Pharmacopeia (USP), a global independent scientific organization, is seeking scientific input on new draft guidelines, “Analytical Procedures for mRNA Vaccine Quality.” USP and a group of leading mRNA experts have identified the need for analytical procedures and best practices to support quality assessments for mRNA vaccines and therapies in development pipelines for infectious diseases, cancer, cystic fibrosis and other disorders.

Doctors Say Medicines Supply Chain Vulnerabilities Impacted Patient Care and Must Be Strengthened

USP Logo
Published on : Published by : BioBuzz Media

The vast majority (95%) of U.S. physicians believe that the COVID-19 pandemic has revealed vulnerabilities in the medicines supply chain that are not going away, and seven out of 10 (73%) feel their trust in the ability of the supply chain to deliver safe, quality medicines has eroded, according to a survey released today by U.S. Pharmacopeia (USP), a global independent scientific organization.[1] A large majority believe the responsibility for solutions falls on multiple stakeholders.